AST’s main risk is sequencing, not concept failure. The company has real control points, but value realization still requires repeated launch success, enough satellites in orbit, regulatory approvals across markets,
gateway and carrier readiness, and proof that monetization is better than plain wholesale capacity. Capital is less binding than before, yet the business remains capital-heavy and the stock already embeds ambitious expectations.